ProfileGDS4459 / ENSG00000181761
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 8% 1% 1% 4% 1% 1% 1% 2% 8% 1% 1% 1% 1% 6% 0% 6% 7% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 12.738
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 21.741
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 31.381
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 42.524
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 51.561
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 61.631
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 71.321
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 81.472
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 92.118
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 101.471
GSM623474group B, liver allograft wedge biopsie placebo treatment 11.791
GSM623475group B, liver allograft wedge biopsie placebo treatment 21.321
GSM623476group B, liver allograft wedge biopsie placebo treatment 31.251
GSM623477group B, liver allograft wedge biopsie placebo treatment 42.686
GSM623478group B, liver allograft wedge biopsie placebo treatment 51.060
GSM623479group B, liver allograft wedge biopsie placebo treatment 62.656
GSM623480group B, liver allograft wedge biopsie placebo treatment 72.757